Subscribe To
ZyVersa Therapeutics’ CEO, Stephen C. Glover to Participate in Panel at the BioFlorida Conference Discussing Inflammation and its Impact on Numerous Diseases
Mr. Glover will also serve as a judge in BioPitch competition for life science companies seeking seed and early-stage investment. ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies – Cholesterol Efflux Mediator™ VAR 200 for treatment of kidney diseases, and Inflammasome ASC Inhibitor IC 100 for […] The post ZyVersa Therapeutics’ CEO, Stephen C. Glover to Participate in Panel at the BioFlorida Conference Discussing Inflammat...
Read More
Posted: Sep 27 2023, 11:07
Author Name: forextv
Views: 101960